Stay updated on CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.

Latest updates to the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check19 days agoChange DetectedA notice was added announcing NIH website updates and explaining that federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.4%

- Check26 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2; the study record history remains unchanged.SummaryDifference0.1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, and the previous revision v3.6.6 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedA new Revision: v3.6.6 entry is added to the record history, and the previous Revision: v3.6.5 is removed from the additions list, reflecting an update to the study record's revision history.SummaryDifference0.1%

Stay in the know with updates to CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.